Yifan Pharmaceutical Co., Ltd. (SHE:002019)

China flag China · Delayed Price · Currency is CNY
12.87
-0.09 (-0.69%)
Jun 27, 2025, 2:45 PM CST
1.66%
Market Cap 15.64B
Revenue (ttm) 5.16B
Net Income (ttm) 393.03M
Shares Out 1.22B
EPS (ttm) 0.33
PE Ratio 39.47
Forward PE 20.74
Dividend 0.20 (1.54%)
Ex-Dividend Date May 29, 2025
Volume 15,107,129
Average Volume 25,186,021
Open 13.25
Previous Close 12.96
Day's Range 12.80 - 13.25
52-Week Range 9.94 - 15.21
Beta 0.98
RSI 49.72
Earnings Date Aug 15, 2025

About Yifan Pharmaceutical

Yifan Pharmaceutical Co., Ltd. engages in the researches and develops, produces, and sells macromolecules, biosimilars, generic drugs, small molecules, synthetic biologics, and special traditional Chinese medicines in China Southeast Asia, Europe, North America, Singapore, South Korea, Italy, Germany, and the United States, and internationally. It offers oral slow controlled release preparations, micron suspensions, micelles for injection, and liquid preparations. The company also focuses on hematologic maliganancies, inflammatory, endocrinolog... [Read more]

Sector Healthcare
Founded 2000
Employees 4,098
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002019
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.